What is Delsys?
Delsys is a specialized technology firm focused on the design, manufacturing, and marketing of advanced products for detecting and measuring electrical signals from muscle contractions. Its comprehensive suite of biosignal sensors, including EKG sensors, Accelerometers, and Foot sensors, is utilized in over 1200 centers globally. The company's technology serves critical applications across research laboratories for neuromuscular system exploration, clinical settings for assessing neuromuscular injury and rehabilitation progress, sports science for enhancing human performance, ergonomics for quantitative task evaluation and human-machine interaction improvement, and biofeedback applications aimed at reducing muscle stress and optimizing movement patterns. This broad utility highlights Delsys's pivotal role in advancing human-centric technology.
How much funding has Delsys raised?
Delsys has raised a total of $1.6M across 2 funding rounds:
Debt
$1M
Debt
$582K
Debt (2020): $1M with participation from PPP
Debt (2021): $582K led by PPP
Key Investors in Delsys
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Delsys?
The recent major strategic investment in Delsys signals a pivotal growth phase, likely enabling the company to scale its operations, expand its product development, and broaden its market reach. With a substantial total funding amount accumulated, Delsys is well-positioned to further innovate in the biosignal sensing domain, potentially exploring new applications or enhancing existing technologies. This capital infusion is expected to solidify its market leadership and drive future advancements in neuromuscular monitoring and performance enhancement technologies.
See full Delsys company page
